UK biotech launches with T cell therapy technology to treat solid tumors
A London-based biotech has emerged from stealth with a personalized T cell therapy platform that it says could create treatments that overcome the usual limitations …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
